Richard D. Carvajal, a clinician and researcher in melanoma and early phase drug development, was named deputy physician-in-chief and director of medical oncology at the Northwell Health Cancer Institute.
Marking a new era of non-invasive medical interventions, the Northwell Health Cancer Institute is investing $1.2 million in the development of cutting-edge histotripsy technology to treat some liver cancer tumors without surgery. This innovative approach uses targeted ultrasound beams to create microbubbles within tumors, effectively disrupting and destroying diseased cells without the need for incisions.
